Premenstrual Dysphoric Disorder: Evidence for a New Category for DSM-5

American Journal of Psychiatry

Volumn 169, Issue 5, 2012, Pages 465-475

  Epperson, C Neill ^{a,b,c,d,e,f,g}   Steiner, Meir ^{a,b,c,d,e,f,g}   Hartlage, S Ann ^{a,b,c,d,e,f,g}   Eriksson, Elias ^{a,b,c,d,e,f,g}   Schmidt, Peter J ^{a,b,c,d,e,f,g}   Jones, Ian ^{a,b,c,d,e,f,g}   Yonkers, Kimberly A ^{a,b,c,d,e,f,g}  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^f CARDIFF UNIVERSITY   (United Kingdom)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ESTRADIOL; GONADORELIN AGONIST; ORAL CONTRACEPTIVE AGENT; PLACEBO; PROGESTERONE; SEROTONIN UPTAKE INHIBITOR;

CAUSAL ATTRIBUTION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DSM-5; DSM-IV; ENVIRONMENTAL FACTOR; EVIDENCE BASED MEDICINE; HUMAN; ILLNESS TRAJECTORY; MENSTRUAL CYCLE; PREMENOPAUSE; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; REVIEW; STRESS; SYMPTOM; SYNDROME DELINEATION;

EID: 84860515249     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2012.11081302     Document Type: Review

References (103)

1. Mason-Hohl E: The Diseases of Women, by Trotula of Salerno: A Translation of Passionibus Mulierum Curandorum by Elizabeth Mason-Hohl, MD. Los Angeles, Ward Ritchie Press, 1940
2. Frank RT: The hormonal causes of premenstrual tension. Arch Neurol Psychiatry 1931; 26:1053-1057
3. Greene R, Dalton K: The premenstrual syndrome. Br Med J 1953; 1:1007-1014
4. Endicott J: History, evolution, and diagnosis of premenstrual dysphoric disorder. J Clin Psychiatry 2000; 61(suppl 12):5-8
5. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd ed, revised (DSM-III-R). Washington, DC, American Psychiatric Association, 1987
6. Hurt SW, Schnurr PP, Severino SK, Freeman EW, Gise LH, Rivera-Tovar A, Steege JF: Late luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints. Am J Psychiatry 1992; 149:525-530
7. Stein DJ, Phillips KA, Fulford KWM, Sadler JZ, Kendler KS: What is a mental/psychiatric disorder? from DSM-IV to DSM-V. Psychol Med 2010; 40:1759-1765
8. Wittchen H, Becker E, Lieb R, Krause P: Prevalence, incidence, and stability of premenstrual dysphoric disorder in the community. Psychol Med 2002; 32:119-132 (Pubitemid 33150508)
9. Rivera-Tovar A, Pilkonis P, Frank E: Symptom patterns in late luteal-phase dysphoric disorder. J Psychopathol Behav Assess 1992; 14:189-199
10. Cohen LS, Soares CN, Otto MW, Sweeney BH, Liberman RF, Harlow BL: Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women: the Harvard Study of Moods and Cycles. J Affect Disord 2002; 70:125-132 (Pubitemid 34765554)
11. Endicott J, Amsterdam J, Eriksson E, Frank E, Freeman E, Hirschfeld R, Ling F, Parry B, Pearlstein T, Rosenblum J, Rubinow D, Schmidt P, Serverino S, Steiner M, Stewart DE, Thys- Jacobs S: Is premenstrual dysphoric disorder a distinct clinical entity? J Womens Health Gend Based Med 1999; 8:663-679 (Pubitemid 29414632)
12. Banerjee N, Roy K, Takkar D: Premenstrual dysphoric disorder: a study from India. Int J Fertil Womens Med 2000; 45:342-344
13. Takeda T, Tasaka K, Sakata M, Murata Y: Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women. Arch Womens Ment Health 2006; 9:209-212 (Pubitemid 43974457)
14. Sveinsdóttir H, Bäckström T: Menstrual cycle symptom variation in a community sample of women using and not using oral contraceptives. Acta Obstet Gynecol Scand 2000; 79:757-764
15. Gehlert S, Song IH, Chang CH, Hartlage SA: The prevalence of premenstrual dysphoric disorder in a randomly selected group of urban and rural women. Psychol Med 2009; 39:129-136
16. Steiner M, Macdougall M, Brown E: The Premenstrual Symptoms Screening Tool (PSST) for clinicians. Archives Womens Ment Health 2003; 6:203-209 (Pubitemid 37046015)
17. Steiner M, Peer M, Palova E, Freeman E, Macdougall M, Soares CN: The Premenstrual Symptoms Screening Tool revised for adolescents (PSST-A): prevalence of severe PMS and premenstrual dysphoric disorder in adolescents. Arch Womens Ment Health 2011; 14:77-81
18. Steiner M, Wilkins A: Diagnosis and assessment of premenstrual dysphoria. Psychiatr Ann 1996; 26:571-575 (Pubitemid 126629172)
19. Meaden PM, Hartlage SA, Cook-Karr J: Timing and severity of symptoms associated with the menstrual cycle in a community- based sample in the Midwestern United States. Psychiatry Res 2005; 134:27-36 (Pubitemid 40460970)
20. Hartlage SA, Freels A, Gotman N, Yonkers KA: Criteria for premenstrual dysphoric disorder: secondary analyses of relevant data sets. Arch Gen Psychiatry 2012; 69:300-305
21. Kendler KS, Silberg JL, Neale MC, Kessler RC, Heath AC, Eaves LJ: Genetic and environmental factors in the aetiology of menstrual, premenstrual, and neurotic symptoms: a population-based twin study. Psychol Med 1992; 22:85-100
22. Kendler KS, Karkowski LM, Corey LA, Neale MC: Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression. Am J Psychiatry 1998; 155:1234-1240 (Pubitemid 28402518)
23. Condon JT: The premenstrual syndrome: a twin study. Br J Psychiatry 1993; 162:481-486
24. Treloar SE, Heath AC, Martin NG: Genetic and environmental influences on premenstrual symptoms in an Australian twin sample. Psychol Med 2002; 32:25-38 (Pubitemid 33150501)
25. van den Akker OB, Stein GS, Neale MC, Murray RM: Genetic and environmental variation in menstrual cycle: histories of two British twin samples. Acta Genet Med Gemellol (Roma) 1987; 36:541-548
26. van den Akker OB, Eves FF, Stein GS, Murray RM: Genetic and environmental factors in premenstrual symptom reporting and its relationship to depression and a general neuroticism trait. J Psychosom Res 1995; 39:477-487
27. Eriksson E, Hedberg MA, Andersch B, Sundblad C: The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 1995; 12:167-176
28. Freeman EW, Rickels K, Sondheimer SJ, Wittmaack FM: Sertraline versus desipramine in the treatment of premenstrual syndrome: an open-label trial. J Clin Psychiatry 1996; 57:7-11 (Pubitemid 26030521)
29. Sundblad C, Modigh K, Andersch B, Eriksson E: Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial. Acta Psychiatr Scand 1992; 85:39-47
30. Steiner M, Korzekwa M, Lamont J, Wilkins A: Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria. Psychopharmacol Bull 1997; 33:771-774 (Pubitemid 28128134)
31. Jermain DM, Preece CK, Sykes RL, Kuehl TJ, Sulak PJ: Luteal phase sertraline treatment for premenstrual dysphoric disorder: results of a double-blind, placebo-controlled, crossover study. Arch Fam Med 1999; 8:328-332
32. Freeman E, Rickels K, Sondheimer S, Polansky M, Xiao S: Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder. Am J Psychiatry 2004; 161:343-351 (Pubitemid 38419285)
33. Halbreich U, Bergeron R, Yonkers KA, Freeman E, Stout AL, Cohen L: Efficacy of intermittent luteal phase sertraline treatment of premenstrual dysphoric disorder. Obstet Gynecol 2002; 100:1219-1229 (Pubitemid 35449188)
34. Cohen LS, Miner C, Brown EW, Freeman E, Halbreich U, Sundell K, McCray S: Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled clinical trial using computerized diaries. Obstet Gynecol 2002; 100:435-444 (Pubitemid 35246128)
35. Yonkers KA, Holthausen GA, Poschman K, Howell HB: Symptom-onset treatment for women with premenstrual dysphoric disorder. J Clin Psychopharmacol 2006; 26:198-202 (Pubitemid 43740347)
36. Steiner M, Hirschberg AL, Bergeron R, Holland F, Gee M, van Erp E: Luteal phase dosing with paroxetine controlled-release in the treatment of premenstrual dysphoric disorder. Am J Obstet Gynecol 2005; 193:352-360 (Pubitemid 41159526)
37. Steiner M, Ravindran A, LeMelledo JM, Carter D, Huang J, Anonychuk A, Simpson S: Luteal-phase administration of paroxetine for the treatment of premenstrual dysphoric disorder: a randomized, double-blind, placebo controlled trial in Canadian women. J Clin Psychiatry 2008; 69:991-998 (Pubitemid 351944955)
38. Pearlstein TB, Bachmann GA, Zacur HA, Yonkers KA: Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception 2005; 72:414-421 (Pubitemid 41676830)
39. Yonkers K, Foegh M: A new low-dose, drospirenone-containing oral contraceptive (OC) with a new dosing regimen is effective in reducing premenstrual dysphoric disorder (PMDD). Fertil Steril 2004; 82(suppl 2):S102-S103
40. Muse KN, Cetel NS, Futterman LA, Yen SC: The premenstrual syndrome: effects of "medical ovariectomy." N Engl J Med 1984; 311:1345-1349 (Pubitemid 15129604)
41. Freeman EW, Sondheimer SJ, Rickels K: Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study. Psychopharmacol Bull 1997; 33:303-309 (Pubitemid 27293125)
42. Brown CS, Ling FW, Anderson RN, Falmer RG, Arheart KL: Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial. Obstet Gynecol 1994; 84:779-786 (Pubitemid 24329844)
43. Leather AT, Studd JWW, Watson NR, Holland EFN: The treatment of severe premenstrual syndrome with goserelin with and without "add-back" estrogen therapy: a placebo-controlled study. Gynecol Endocrinol 1999; 13:48-55 (Pubitemid 29265520)
44. Bancroft J, Boyle H, Warner P, Fraser HM: The use of an LHRH agonist, buserelin, in the long-term management of premenstrual syndromes. Clin Endocrinol (Oxf) 1987; 27:171-182 (Pubitemid 17093749)
45. Wyatt KM, Dimmock PW, Ismail KM, Jones PW, O'Brien PM: The effectiveness of GnRHa with and without "add-back" therapy in treating premenstrual syndrome: a meta-analysis. BJOG 2004; 111:585-593 (Pubitemid 38746243)
46. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR: Differential behavioral effects of gonadal steriods in women with and in those without premenstrual syndrome. N Engl J Med 1998; 338:209-216 (Pubitemid 28047573)
47. Stout AL, Grady TA, Steege JF, Blazer DG, George LK, Melville ML: Premenstrual symptoms in black and white community samples. Am J Psychiatry 1986; 143:1436-1439 (Pubitemid 17176104)
48. Fontana AM, Palfai TG: Psychosocial factors in premenstrual dysphoria: stressors, appraisal, and coping processes. J Psychosom Res 1994; 38:557-567 (Pubitemid 24256714)
49. Girdler S, Straneva P, Light K, Pederson C, Morrow A: Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry 2001; 49:788-797 (Pubitemid 32452300)
50. Deuster P, Adera T, South-Paul J: Biological, social, and behavioral factors associated with premenstrual syndrome. Arch Fam Med 1999; 8:122-128
51. Pilver CE, Levy BR, Libby DJ, Desai RA: Posttraumatic stress disorder and trauma characteristics are correlates of premenstrual dysphoric disorder. Arch Womens Ment Health 2011; 14:383-393
52. Golding J, Taylor D, Menard L, King M: Prevalence of sexual abuse history in a sample of women seeking treatment for premenstrual syndrome. J Psychsom Obstet Gynaecol 2000; 21:69-80 (Pubitemid 30455938)
53. Perkonigg A, Yonkers K, Pfister H, Lieb R, Wittchen HU: Risk factors for premenstrual dysphoric disorder in a community sample of young women: the role of traumatic events and posttraumatic stress disorder. J Clin Psychiatry 2004; 65:1314-1322
54. Maskall DD, Lam RW, Misri S, Carter D, Kuan AJ, Yatham LN, Zis AP: Seasonality of symptoms in women with late luteal phase dysphoric disorder. Am J Psychiatry 1997; 154:1436-1441 (Pubitemid 27415613)
55. Praschak-Rieder N, Willeit M, Neumeister A, Hilger E, Stastny J, Thierry N, Lenzinger E, Kasper S: Prevalence of premenstrual dysphoric disorder in female patients with seasonal affective disorder. J Affect Disord 2001; 63:239-242 (Pubitemid 32200520)
56. Kim DR, Czarkowski KA, Epperson CN: The relationship between bipolar disorder, seasonality, and premenstrual symptoms. Curr Psychiatry Rep 2011; 13:500-503
57. De Ronchi D, Ujkaj M, Boaron F, Muro A, Piselli M, Quartesan R: Symptoms of depression in late luteal phase dysphoric disorder: a variant of mood disorder? J Affect Disord 2005; 86:169-174 (Pubitemid 40780029)
58. Kim D, Gyulai L, Freeman E, Morrison M, Baldassano C, Dube B: Premenstrual dysphoric disorder and psychiatric co-morbidity. Arch Womens Ment Health 2004; 7:37-47 (Pubitemid 38280069)
59. Halbreich U, Endicott J: Relationship of dysphoric premenstrual changes to depressive disorder. Acta Psychiatr Scand 1985; 71:331-338 (Pubitemid 15114469)
60. Mackenzie TB, Wilcox K, Baron H: Lifetime prevalence of psychiatric disorders in women with perimenstrual difficulties. J Affect Disord 1986; 10:15-19 (Pubitemid 16109821)
61. Fava M, Pedrazzi F, Guaraldi GP, Romano G, Genazzani AR, Facchinetti F: Comorbid anxiety and depression among patients with late luteal phase dysphoric disorder. J Anxiety Disord 1992; 6:325-335
62. Pearlstein TB, Frank E, Rivera-Tovar A, Thoft JS, Jacobs E, Mieczkowski TA: Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder. J Affect Disord 1990; 20:129-134 (Pubitemid 20316955)
63. Rubinow DR, Smith MJ, Schenkel LA, Schmidt PJ, Dancer K: Facial emotion discrimination across the menstrual cycle in women with premenstrual dysphoric disorder (PMDD) and controls. J Affect Disord 2007; 104:37-44 (Pubitemid 350080996)
64. Keenan PA, Lindamer LA, Jong SK: Menstrual phase-independent retrieval deficit in women with PMS. Biol Psychiatry 1995; 38:369-377
65. Critchlow DG, Bond AJ, Wingrove J: Mood disorder history and personality assessment in premenstrual dysphoric disorder. J Clin Psychiatry 2001; 62:688-693 (Pubitemid 32994931)
66. De Ronchi D, Muro A, Marziani A, Rucci P: Personality disorders and depressive symptoms in late luteal phase dysphoric disorder. Psychother Psychosom 2000; 69:27-34
67. Epperson CN, Haga K, Mason GF, Sellers E, Gueorguieva R, Zhang W, Weiss E, Rothman DL, Krystal JH: Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 2002; 59:851-858 (Pubitemid 35001151)
68. Backstrom T, Sanders D, Leask R, Davidson D, Warner P, Bancroft J: Mood, sexuality, hormones, and the menstrual cycle, II: hormone levels and their relationship to the premenstrual syndrome. Psychosom Med 1983; 45:503-506
69. Bloch M, Schmidt PJ, Su T-P, Tobin MB, Rubinow DR: Pituitary-adrenal hormones and testosterone across the menstrual cycle in women with premenstrual syndrome and controls. Biol Psychiatry 1998; 43:897-903 (Pubitemid 28288528)
70. Eriksson E, Sundblad C, Lisjö P, Modigh K, Andersch B: Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls. Psychoneuroendocrinology 1992; 17:195-204
71. Facchinetti F, Genazzani AD, Martignoni E, Fioroni L, Nappi G, Genazzani AR: Neuroendocrine changes in luteal function in patients with premenstrual syndrome. J Clin Endocrinol Metab 1993; 76:1123-1127 (Pubitemid 23155423)
72. Reame NE, Marshall JC, Kelch RP: Pulsatile LH secretion in women with premenstrual syndrome (PMS): evidence for normal neuroregulation of the menstrual cycle. Psychoneuroendocrinology 1992; 17:205-213
73. Redei E, Freeman EW: Preliminary evidence for plasma adrenocorticotropin levels as biological correlates of premenstrual symptoms. Acta Endocrinol 1993; 128:536-542 (Pubitemid 23197629)
74. Rubinow DR, Hoban MC, Grover GN, Galloway DS, Roy-Byrne P, Andersen R, Merriam GR: Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. Am J Obstet Gynecol 1988; 158:5-11 (Pubitemid 18043325)
75. Steiner M, Haskett RF, Carroll BJ, Hays SE, Rubin RT: Circadian hormone secretory profiles in women with severe premenstrual tension syndrome. Br J Obstet Gynaecol 1984; 91:466-471 (Pubitemid 14146231)
76. Thys-Jacobs S, McMahon D, Bilezikian JP: Differences in free estradiol and sex hormone-binding globulin in women with and without premenstrual dysphoric disorder. J Clin Endocrinol Metab 2008; 93:96-102
77. Wang M, Seippel L, Purdy RH, Bäckström T: Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J Clin Endocrinol Metab 1996; 81:1076-1082
78. Rapkin AJ, Morgan M, Goldman L, Brann DW, Simone D, Mahesh VB: Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol 1997; 90:709-714 (Pubitemid 27449718)
79. Seippel L, Bäckström T: Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome. J Clin Endocrinol Metab 1998; 83:1988-1992 (Pubitemid 28496326)
80. Protopopescu X, Tuescher O, Pan H, Epstein J, Root J, Chang L, Altemus M, Polanecsky M, McEwen B, Stern E, Silbersweig D: Toward a functional neuroanatomy of premenstrual dysphoric disorder. J Affect Disord 2008; 108:87-94 (Pubitemid 351418017)
81. Rapkin AJ, Berman SM, Mandelkern MA, Silverman DH, Morgan M, London ED: Neuroimaging evidence of cerebellar involvement in premenstrual dysphoric disorder. Biol Psychiatry 2011; 69:374-380
82. Sundström I, Bäckström T: Patients with premenstrual syndrome have decreased saccadic eye velocity compared to control subjects. Biol Psychiatry 1998; 44:755-764
83. Sundström I, Andersson A, Nyberg S, Ashbrook D, Purdy RH, Bäckström T: Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 1998; 67:126-138
84. Smith MJ, Adams LF, Schmidt PJ, Rubinow DR, Wassermann EM: Abnormal luteal phase excitability of the motor cortex in women with premenstrual syndrome. Biol Psychiatry 2003; 54:757-762 (Pubitemid 37281393)
85. Epperson CN, Pittman B, Czarkowski KA, Stiklus S, Krystal JH, Grillon C: Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder. Neuropsychopharmacology 2007; 32:2190-2198 (Pubitemid 47417699)
86. Kask K, Gulinello M, Bäckström T, Geyer MA, Sundström-Poromaa I: Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle. Neuropsychopharmacology 2008; 33:2283-2290 (Pubitemid 351992075)
87. Yonkers KA, White K: Premenstrual exacerbation of depression: one process or two? J Clin Psychiatry 1992; 53:289-292
88. Hartlage S, Brandenburg D, Kravitz H: Premenstrual exacerbation of depressive disorders in a community-based sample in the United States. Psychosom Med 2004; 66:698-706 (Pubitemid 39332356)
89. Bloch M, Schmidt PJ, Rubinow DR: Premenstrual syndrome: evidence for symptom stability across cycles. Am J Psychiatry 1997; 154:1741-1746 (Pubitemid 27516593)
90. de la Gándara Martín JJ: [Premenstrual dysphoric disorder: long-term treatment with fluoxetine and discontinuation.] Actas Luso Esp Neurol Psiquiatr Cienc Afines 1997; 25:235-242 (Spanish)
91. Sundblad C, Wikander I, Andersch B, Eriksson E: A naturalistic study of paroxetine in premenstrual syndrome: efficacy and side effects during ten cycles of treatment. Eur Neuropsychopharmacol 1997; 7:201-206 (Pubitemid 27278488)
92. Freeman EW, Rickels K, Sammel MD, Lin H, Sondheimer SJ: Time to relapse after short- or long-term treatment of severe premenstrual syndrome with sertraline. Arch Gen Psychiatry 2009; 66:537-544
93. Metcalf MG, Braiden V, Livesey JH: Symptom cyclicity in women with the premenstrual syndrome: an 8-year follow-up study. J Psychosom Res 1992; 36:237-241
94. Roca CA, Schmidt PJ, Rubinow DR: A follow-up study of premenstrual syndrome. J Clin Psychiatry 1999; 60:763-766
95. Freeman EW, Rickels K, Sondheimer SJ: Course of premenstrual syndrome symptom severity after treatment. Am J Psychiatry 1992; 149:531-533
96. Dimmock P, Wyatt K, Jones P, O'Brien S: Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 2000; 356:1131-1136
97. Yonkers KA, Pearlstein T, Fayyad R, Gillespie JA: Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase. J Affect Disord 2005; 85:317-321 (Pubitemid 40386515)
98. Yang M, Wallenstein G, Hagan M, Guo A, Chang J, Kornstein S: Burden of premenstrual dysphoric disorder on health-related quality of life. J Womens Health (Larchmt) 2008; 17:113-121 (Pubitemid 351197540)
99. Pearlstein T, Halbreich U, Batzar E, Brown C, Endicott J, Frank E, Freeman EW, Harrison WM, Haskett RF, Stout AL, Yonkers KA: Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo. J Clin Psychiatry 2000; 61:101-109 (Pubitemid 30141642)
100. Halbreich U, Borenstein J, Pearlstein T, Kahn LS: The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 2003; 28(suppl 3):1-23 (Pubitemid 39658675)
101. Steiner M, Brown E, Trzepacz P, Dillon J, Berger C, Carter D, Reid R, Stewart D: Fluoxetine improves functional work capacity in women with premenstrual dysphoric disorder. Arch Womens Ment Health 2003; 6:71-77 (Pubitemid 36356283)
102. Pearlstein T: Premenstrual dysphoric disorder: out of the appendix. Arch Womens Ment Health 2010; 13:21-23
103. O'Brien PM, Bäckström T, Brown C, Dennerstein L, Endicott J, Epperson CN, Eriksson E, Freeman E, Halbreich U, Ismail KM, Panay N, Pearlstein T, Rapkin A, Reid R, Schmidt P, Steiner M, Studd J, Yonkers K: Towards a consensus on diagnostic criteria, measurement, and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health 2011; 14:13-21